Keratoconus exhibits a focal biomechanical modification rather than a uniform generalized weakness. A differential biomechanical weakening in the area of the cone, with a greater efficacy of cone centric treatments for the reduction of corneal curvature has been demonstrated. Clinical application of this principle forms the basis of customized cross-linking (PiXL). A handful of studies report promising results with this novel technique, demonstrating corneal surface regularization and visual improvement.
We present the case of a 14-year-old who underwent PiXL using an epithelium-off approach in the right eye for progressive keratoconus [Fig. 1a]. Ultraviolet A irradiation of 5.4, 10, and 15 J/cm2 was applied in three concentric circles (7 mm, 5 mm, and 3 mm, respectively) centered on the maximum elevation of the posterior float, using the Mosaic delivery system (KXL II, Avedro Inc., Waltham, MA, USA). A mean keratometric reduction of 1.4 D [Fig. 1b and c] with a subsequent improvement in best-corrected distance visual acuity from 6/12 to 6/7.5 was noted at 3-months, with a subsequent stabilization up till 1-year follow-up [Fig. 1d]. No visually significant haze or endothelial cell loss was noted. The fellow eye was within normal limits.
In our case, the treatment was centered on the maximum posterior float elevation. The use of varying treatment patterns including customized toric, asymmetric arcuates, and concentric circles has been described. In a majority of the earlier studies, the treatment was centered on the area of greatest curvature. However, centration of irradiation around the maximum point of posterior float elevation may be more intuitive since pachymetry as well as curvature is modulated by epithelial thickness and tear film.
In conclusion, we describe the clinical changes that ensue following PiXL over a 1-year follow-up. This ophthalmic image highlights the corneal tomographic changes and adds to the limited literature on this novel technique.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
1. Roberts CJ, Dupps WJ Jr. Biomechanics of corneal ectasia and biomechanical treatments J Cataract Refract Surg. 2014;40:991–8
2. Sinha Roy A, Dupps WJ Jr. Patient-specific computational modeling of keratoconus
progression and differential responses to collagen cross-linking Invest Ophthalmol Vis Sci. 2011;52:9174–87
3. Kanellopoulos AJ, Dupps WJ, Seven I, Asimellis G. Toric topographically customized transepithelial, pulsed, very high-fluence, higher energy and higher riboflavin concentration collagen cross-linking in keratoconus
Case Rep Ophthalmol. 2014;5:172–80
4. Nordström M, Schiller M, Fredriksson A, Behndig A. Refractive improvements and safety with topography-guided corneal crosslinking for keratoconus
: 1-year results Br J Ophthalmol. 2017;101:920–5
5. Seiler TG, Fischinger I, Koller T, Zapp D, Frueh BE, Seiler T, et al Customized corneal cross-linking: One-year results Am J Ophthalmol. 2016;166:14–21